143 related articles for article (PubMed ID: 11469693)
1. Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer.
Korkolopoulou P; Konstantinidou AE; Kavantzas N; Patsouris E; Pavlopoulos PM; Christodoulou P; Thomas-Tsagli E; Davaris P
Virchows Arch; 2001 Jun; 438(6):603-11. PubMed ID: 11469693
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of angiogenesis in superficial bladder cancer.
Stavropoulos NE; Bouropoulos C; Ioachim IE; Michael M; Hastazeris K; Tsimaris I; Kalogeras D; Liamis Z; Stefanaki S; Agnantis NI
Int Urol Nephrol; 2004; 36(2):163-7. PubMed ID: 15368686
[TBL] [Abstract][Full Text] [Related]
3. Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis.
Canoğlu A; Göğüş C; Bedük Y; Orhan D; Tulunay O; Baltaci S
Int Urol Nephrol; 2004; 36(3):401-5. PubMed ID: 15783115
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.
Bochner BH; Cote RJ; Weidner N; Groshen S; Chen SC; Skinner DG; Nichols PW
J Natl Cancer Inst; 1995 Nov; 87(21):1603-12. PubMed ID: 7563203
[TBL] [Abstract][Full Text] [Related]
5. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
Korkolopoulou P; Apostolidou E; Pavlopoulos PM; Kavantzas N; Vyniou N; Thymara I; Terpos E; Patsouris E; Yataganas X; Davaris P
Leukemia; 2001 Sep; 15(9):1369-76. PubMed ID: 11516097
[TBL] [Abstract][Full Text] [Related]
7. The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis.
Herrmann E; Bögemann M; Bierer S; Eltze E; Toma MI; Köpke T; Hertle L; Wülfing C
Oncol Rep; 2007 Jul; 18(1):133-8. PubMed ID: 17549358
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of micro-vessel density in cancer of the urinary bladder.
Chaudhary R; Bromley M; Clarke NW; Betts CD; Barnard RJ; Ryder WD; Kumar S
Anticancer Res; 1999; 19(4C):3479-84. PubMed ID: 10629639
[TBL] [Abstract][Full Text] [Related]
10. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?
Sağol O; Yörükoğlu K; Sis B; Tuna B; Ozer E; Güray M; Mungan U; Kirkali Z
Urology; 2001 May; 57(5):895-9. PubMed ID: 11337289
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
12. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas.
Dickinson AJ; Fox SB; Persad RA; Hollyer J; Sibley GN; Harris AL
Br J Urol; 1994 Dec; 74(6):762-6. PubMed ID: 7530131
[TBL] [Abstract][Full Text] [Related]
13. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer].
Ogura Y; Sato K; Kato T; Saito K; Enomoto K
Nihon Hinyokika Gakkai Zasshi; 1998 May; 89(5):529-37. PubMed ID: 9642990
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
Theodoropoulos VE; Lazaris ACh; Sofras F; Gerzelis I; Tsoukala V; Ghikonti I; Manikas K; Kastriotis I
Eur Urol; 2004 Aug; 46(2):200-8. PubMed ID: 15245814
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma.
Li G; Yang T; Li L; Yan J; Zeng Y; Yu J; Zhang Y
Colloids Surf B Biointerfaces; 2004 Aug; 37(1-2):15-9. PubMed ID: 15450303
[TBL] [Abstract][Full Text] [Related]
18. Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis.
Offersen BV; Knap MM; Marcussen N; Horsman MR; Hamilton-Dutoit S; Overgaard J
Br J Cancer; 2002 Dec; 87(12):1422-30. PubMed ID: 12454772
[TBL] [Abstract][Full Text] [Related]
19. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
20. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
